|
1
|
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.
|
J Clin Lipidol
|
2015
|
1.88
|
|
2
|
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher.
|
Cardiovasc Drugs Ther
|
2016
|
1.46
|
|
3
|
Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension.
|
Eur Heart J
|
2013
|
0.92
|
|
4
|
Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.
|
Atherosclerosis
|
2017
|
0.75
|